What is Daiichinkyo Co Operating Cash Flow per Share?
Daiichinkyo Co's operating cash flow per share for the
three
months ended in Mar. 2024 was $0.10.
Daiichinkyo Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $2.16.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Daiichinkyo Co was 423.30% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 46.70% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 24.10% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Daiichinkyo Co's Operating Cash Flow per Share or its related term are showing as below:
DSKYF'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -35.8 Med: 5.9 Max: 56.4
Current: 46.7
During the past 13 years, Daiichinkyo Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.40% per year. The lowest was -35.80% per year. And the median was 5.90% per year.
Daiichinkyo Co Operating Cash Flow per Share Historical Data
The historical data trend for Daiichinkyo Co's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiichinkyo Co Operating Cash Flow per Share Chart
|
Daiichinkyo Co Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Operating Cash Flow per Share |
|
Get a 7-Day Free Trial
|
|
|
0.94 |
0.91 |
0.61 |
0.45 |
2.09 |
|
Daiichinkyo Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Operating Cash Flow per Share |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
0.13 |
-0.17 |
-0.06 |
2.29 |
0.10 |
Competitive Comparison of Daiichinkyo Co's Operating Cash Flow per Share
For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiichinkyo Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Daiichinkyo Co's Price-to-Operating-Cash-Flow falls into.
Daiichinkyo Co Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Daiichinkyo Co's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as
Daiichinkyo Co's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.16
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiichinkyo Co (Daiichinkyo Co) Business Description
Traded in Other Exchanges
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.
Daiichinkyo Co (Daiichinkyo Co) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DSKYF has been successfully added to your